Atopic Dermatitis Clinical Trials in Boston, Massachusetts

3 studies are recruiting for atopic dermatitis in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

    Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study aims to provide data on the efficacy an…

    Stage
    Phase 3
    Ages
    18 to 63
    Site
    Boston Specialists /ID# 265810, Boston, Massachusetts
    Locations
    128 in total
    Run by
    AbbVie

    See if you can join NCT06389136 on ClinicalTrials.gov

  2. Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

    This protocol is primarily looking to see if the IL-4Ra R576 polymorphism is associated with increased clinical, immunological and microbial markers of disease activity in patients with Atopic dermatitis.

    Stage
    Not phased
    Ages
    6 to 65
    Site
    Boston Children's Hospital, Boston, Massachusetts
    Run by
    Boston Children's Hospital

    See if you can join NCT04455906 on ClinicalTrials.gov

  3. An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

    The objective of this study is to describe and compare the incidence of adverse pregnancy outcomes (spontaneous abortion/miscarriage, stillbirth) and prevalence of adverse infant outcomes (major congenital malformations [MCMs], small for gestational age [SGA]) in women with AD who are treated with …

    Stage
    Not phased
    Ages
    18 to 49
    Site
    Regeneron Research Site, Boston, Massachusetts
    Run by
    Regeneron Pharmaceuticals

    See if you can join NCT03936335 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.